Initial cell maturity changes following transplantation in a hyaluronan-based hydrogel and impacts therapeutic success in the stroke-injured rodent brain.


Journal

Biomaterials
ISSN: 1878-5905
Titre abrégé: Biomaterials
Pays: Netherlands
ID NLM: 8100316

Informations de publication

Date de publication:
02 2019
Historique:
received: 15 08 2018
revised: 31 10 2018
accepted: 12 11 2018
pubmed: 24 11 2018
medline: 12 3 2020
entrez: 24 11 2018
Statut: ppublish

Résumé

Ischemic stroke results in a loss of neurons for which there are no available clinical strategies to stimulate regeneration. While preclinical studies have demonstrated that functional recovery can be obtained by transplanting an exogenous source of neural progenitors into the brain, it remains unknown at which stage of neuronal maturity cells will provide the most benefit. We investigated the role of neuronal maturity on cell survival, differentiation, and long-term sensorimotor recovery in stroke-injured rats using a population of human cortically-specified neuroepithelial progenitor cells (cNEPs) delivered in a biocompatible, bioresorbable hyaluronan/methylcellulose hydrogel. We demonstrate that transplantation of immature cNEPs result in the greatest tissue and functional repair, relative to transplantation of more mature neurons. The transplantation process itself resulted in the least cell death and phenotypic changes in the immature cNEPs, and the greatest acute cell death in the mature cells. The latter negatively impacted host tissue and negated any potential positive effects associated with cell maturity and the hydrogel vehicle, which itself showed some functional and tissue benefit. Moreover, we show that more mature cell populations are drastically altered during the transplantation process itself. The phenotype of the cells before and after transplantation had an enormous impact on their survival and the consequent tissue and behavioral response, emphasizing the importance of characterizing injected cells in transplantation studies more broadly.

Identifiants

pubmed: 30468998
pii: S0142-9612(18)30797-X
doi: 10.1016/j.biomaterials.2018.11.020
pii:
doi:

Substances chimiques

Hydrogels 0
Hyaluronic Acid 9004-61-9

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

309-322

Subventions

Organisme : CIHR
Pays : Canada

Informations de copyright

Copyright © 2018. Published by Elsevier Ltd.

Auteurs

Samantha L Payne (SL)

Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, Ontario, M5S3E1, Canada; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Ontario, M5S3E1, Canada.

Anup Tuladhar (A)

Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Ontario, M5S3E1, Canada.

Jaclyn M Obermeyer (JM)

Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, Ontario, M5S3E1, Canada; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Ontario, M5S3E1, Canada.

Balazs V Varga (BV)

Wellcome Trust Medical Research Council Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK.

Carter J Teal (CJ)

Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Ontario, M5S3E1, Canada.

Cindi M Morshead (CM)

Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Ontario, M5S3E1, Canada; Institute of Medical Science, University of Toronto, Toronto, Ontario, M5S3E1, Canada; Department of Surgery, Division of Anatomy, University of Toronto, Toronto, Ontario, M5S3E1, Canada.

Andras Nagy (A)

Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, M5G1X5, Canada.

Molly S Shoichet (MS)

Department of Chemical Engineering and Applied Chemistry, University of Toronto, Toronto, Ontario, M5S3E1, Canada; Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto, Ontario, M5S3E1, Canada; Department of Chemistry, University of Toronto, Toronto, Ontario, M5S3E1, Canada. Electronic address: molly.shoichet@utoronto.ca.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH